Antigenic modulation in vitro. II. Modulation of thymus-leukemia (TL) antigenicity requires complement component C3.
D000818:Animals; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D003176:Complement C3; D003181:Complement C4; D004546:Elapid Venoms / Q000494:pharmacology; D005615:Freezing; D006358:Hot Temperature; D007165:Immunosuppression Therapy; D007942:Leukemia, Experimental / Q000276:immunology*; D051379:Mice; D015054:Zymosan / Q000494:pharmacology
D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D003176:Complement C3; D003181:Complement C4; D004546:Elapid Venoms; D015054:Zymosan